Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?

Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?

Source: 
Fierce Pharma
snippet: 

Finding the perfect name is no easy task for a new company, particularly in the exotic world of biopharma monikers. Mylan and Pfizer's Upjohn, working to close their generics megamerger, believe they have a name that strikes the right tone––even if that name is very familiar to one of the partners.